Shares surge on massive volume after EPS Ventures announced its intention to acquire LNG shipping firm Cool Company.
A flurry of multi-billion dollar acquisitions by Pfizer, Genmab, and Axcelis signals renewed confidence and strategic positioning in high-growth sectors.
Key approvals and fast-track designations for Insmed, Alto Neuroscience, and Corcept Therapeutics boost investor confidence in the industry's regulatory landscape.
The deal paves the way for the integration of Monogram's advanced surgical robotics, with a closing date set for early October 2025.
Gaming giant to be acquired by a private equity consortium including Silver Lake and Saudi Arabia's PIF at a 25% premium, sending shares higher.
Singapore-based gaming and technology firm SACH Pte. Ltd. is set for a NASDAQ listing through the proposed combination.
The regional banking giant has now cleared all regulatory hurdles for its pending all-stock transaction with Veritex Holdings, set to close in 2025.
Zepzelca, in combination with Roche's Tecentriq, is the first approved first-line maintenance therapy for extensive-stage small cell lung cancer.